Nephroprotective effects with SGLT2i in CKD patients

3' education - Aug. 30, 2020 - Prof. Hiddo Heerspink, PhD - Groningen, The Netherlands

Educational information

This video was recorded during the ESC Congress 2020.

Faculty

Prof. Hiddo Heerspink, PhD is a clinical pharmacologist at the University Medical Center Groningen (UMCG) in the Netherlands

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the DAPA-CKD trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.